Benzodiazepine, psychotropic medication, and dementia: A population‐based cohort study
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Introduction: Benzodiazepine use has been associated with increased risk of dementia. However, it remains unclear whether the risk relates to short or long half‐life benzodiazepines and whether it extends to other psychotropic drugs. Methods: Prospective cohort study among 8240 individuals ≥65, interviewed on medication use. Incident dementia confirmed by an end point committee after a multistep procedure. Results: During a mean of 8 years of follow‐up, 830 incident dementia cases were observed. Users of benzodiazepines at baseline had a 10% increased risk of dementia (adjusted hazard ratio [HR], 1.10; 95% confidence interval, 0.90–1.34). However, long half‐life (>20 hours) benzodiazepine users had a marked increased risk of dementia (HR = 1.62; 1.11–2.37) compared with short half‐life users (HR = 1.05; 0.85–1.30). Users of psychotropics had an increased risk of dementia (HR = 1.47; 1.16–1.86). Discussion: Results of this large, prospective study show increased risk of dementia for long half‐life benzodiazepine and psychotropic use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2003) · Neuroepidemiology · doi:10.1159/000072920 · Cited by 672
Tannenbaum, C., Paquette, A., Hilmer, S., Holroyd-Leduc, J., & Carnahan, R. (2012) · Drugs & Aging · doi:10.1007/bf03262280 · Cited by 241
Fourrier, A., Letenneur, L., Dartigues, J., Moore, N., & Bégaud, B. (2001) · European Journal of Clinical Pharmacology · doi:10.1007/s002280100326 · Cited by 158 · cited 1×
“The prevalence of use for benzodiazepines alone among patients aged 65 years is estimated to be 30% in France, 20% in Canada and Spain, and approximately 15% in Australia [2–5].”
BackgroundSelf-citationSex Differences in the Association between Alcohol Consumption and Cognitive Performance
Dufouil, C., Ducimeti re, P., Ducimeti re, P., Alp rovitch, A., & for the EVA Study Group (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009293 · Cited by 157
Self-citation
Cited by
GWAS on family history of Alzheimer’s disease
Marioni, R. E., Harris, S. E., Zhang, Q., McRae, A. F., Hagenaars, S. P., Hill, W. D., Davies, G., Ritchie, C. W., Gale, C. R., Starr, J. M., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0150-6 · Cited by 564
Transethnic genome‐wide scan identifies novel Alzheimer's disease loci
Jun, G. R., Chung, J., Mez, J., Barber, R., Beecham, G. W., Bennett, D. A., Buxbaum, J. D., Byrd, G. S., Carrasquillo, M. M., Crane, P. K., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.12.012 · Cited by 197
Lucchetta, R. C., da Mata, B. P. M., & Mastroianni, P. D. C. (2018) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2170 · Cited by 130
Gomez, A. F., Barthel, A. L., & Hofmann, S. G. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1472767 · Cited by 125
“future development of cognitive decline [41].”
Association between daily sleep duration and risk of dementia and mortality in a Japanese community
Ohara, T., Honda, T., Hata, J., Yoshida, D., Mukai, N., Hirakawa, Y., Shibata, M., Kishimoto, H., Kitazono, T., Kanba, S., et al. (2018) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15446 · Cited by 111
Metadata
- Authors
- Shash, D., Kurth, T., Bertrand, M., Dufouil, C., Barberger‐Gateau, P., Berr, C., Ritchie, K., Dartigues, J., Bégaud, B., Alpérovitch, A., & Tzourio, C.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2015-11-19
- Volume
- 12
- Issue
- 5
- Pages
- 604-613
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2234730733
- Cited by
- 94
- References
- 4
- FWCI
- 7.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Benzodiazepine, psychotropic medication, and dementia: A population‐based cohort study. https://app.cochat.ai/papers/10.1016/j.jalz.2015.10.006
- The paper
- Shash, D., Kurth, T., Bertrand, M., Dufouil, C., Barberger‐Gateau, P., Berr, C., Ritchie, K., Dartigues, J., Bégaud, B., Alpérovitch, A., & Tzourio, C. (2016). Benzodiazepine, psychotropic medication, and dementia: A population‐based cohort study. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2015.10.006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.